Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

6,677 evidence items · page 125 / 268

26.31 %The triple mutant HGEAA haplotype in Pfdhps had a prevalence of 26.31% in Kisumu and 44.68% in Kisii.

Kenyapaludismepublished 2025Malaria journalPubMeddocument of 14 observations

82 casesIn the per-protocol analysis, 82 of 415 children in the RTS,S/AS01E group had a first or only clinical malaria episode by 12 months.

Kenyapaludismepublished 2011The Lancet. Infectious diseaseseurope_pmcdocument of 6 observationsDOI 10.1016/s1473-3099(10)70262-0

1 infective_bite_per_yearThe average number of infective bites received by children was still greater than one a year in hamlets where bednets were used.

Kenyapaludismepublished 1989Medical and veterinary entomologyeurope_pmcdocument of 7 observations

0.3 %The percentage of HIV infections with PrEP-associated nucleoside reverse transcriptase inhibitor (NRTI) drug resistance was 0.3% in the antibody rapid diagnostic testing scenario.

KenyaVIH/sidapublished 2024The lancet. HIVPubMeddocument of 6 observations

24 %Health facility blood smear results led to undertreatment of 24% of patients and overtreatment of 8% of patients compared to slide 2 (gold standard).

Kenyapaludismepublished 2026Malaria journalPubMeddocument of 10 observations

78 %78% of the participants preferred full disclosure of their HIV status by 12 years of age.

KenyaVIH/sidaobserved 2019published 2023Frontiers in public healthPubMeddocument of 18 observations

3.9 per_100_person_monthsThe overall rate of first viral rebound was 3.9 per 100 person-months in Nakuru.

KenyaVIH/sidapublished 2020International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 9 observations

92 %Among HIV-infected children in Kenya, 92% were receiving antiretroviral therapy (ART) in 2018.

KenyaVIH/sidaobserved 2018published 2022PloS onePubMeddocument of 10 observations

49 %Candida albicans constituted 49.0% (n=24) of the total yeasts isolated.

Kenyayeast infectionpublished 2021The Pan African medical journaleurope_pmcdocument of 8 observations

49 %An intervention that halves the risk of malaria episodes would reduce the prevalence of iron deficiency in African children by 49%.

Kenyairon deficiency · paludismepublished 2021Nature medicineeurope_pmcdocument of 3 observations

8 countriesAnopheles stephensi has been identified in eight African countries as of 2025: Ethiopia, Sudan, Somaliland, Eritrea, Nigeria, Kenya, Ghana and Niger.

Kenyapaludismeobserved 2025published 2026Scientific reportsPubMeddocument of 3 observations

32,559 participantsThe meta-analysis included 51 studies involving 32,559 participants on Chlamydia trachomatis in Kenya.

KenyaChlamydia trachomatispublished 2025BMC infectious diseasesPubMeddocument of 4 observations

3.64 prevalence_rate_ratioThe prevalence rate ratio for HIV counseling in intervention versus control facilities in the final study quarter was 3.64.

KenyaVIH/sidapublished 2022Implementation science : ISeurope_pmcdocument of 6 observationsDOI 10.1186/s13012-022-01242-3

75 %The sensitivity of the verbal autopsy technique was greater than 75% for measles, neonatal tetanus, malnutrition, and trauma-related deaths.

Kenyamalnutrition · neonatal tetanus · rougeole · trauma-related deathspublished 1992Lancet (London, England)europe_pmcdocument of 3 observations

85 %Most HIV-1 transmission clusters (85%) consisted of sequences from the same risk group.

KenyaVIH/sidaobserved 2005-2019published 2020Scientific reportsPubMeddocument of 9 observations

78.7 %A majority (78.7%) of the 705 HIV patients had a history of opportunistic infections during their antiretroviral therapy lifetime.

KenyaVIH/sidapublished 2023BioMed research internationalPubMeddocument of 6 observations

55.9 %Among Kenyan adolescents aged 15–19 years in Kisumu with no prior PrEP use, boys were more willing than girls to consider using PrEP (55.9% vs. 49.7%).

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 15 observations

65 %Approximately 65% of the cancer cases with known stage at diagnosis were in stages III and IV.

Kenyacancer (non précisé)published 2025PloS oneeurope_pmcdocument of 7 observations

61 per_1000Overall prevalence for any neurological impairment decreased from 61 per 1000 in 2001 to 44.7 per 1000 in 2015.

Kenyaneurological impairmentobserved 2001published 2022Developmental medicine and child neurologyeurope_pmcDOI 10.1111/dmcn.15059

201 casesAmong 740 livebirths, 201 (27.2%) were preterm.

Kenyapreterm birthpublished 2022AIDS (London, England)PubMeddocument of 10 observations

20.7 %20.7% of the studies on HCV in Kenya included injection drug users.

Kenyahépatite Cpublished 2024Journal of epidemiology and global healthPubMeddocument of 8 observations

91 %Evolution of drug resistance mutations was detected in 91% of 22 participants with short-term follow-up in a cohort of Kenyan children and adolescents living with HIV failing first-line antiretroviral therapy.

KenyaVIH/sidapublished 2023VirusesPubMeddocument of 6 observations

The number of bacterial vaginosis diagnoses in this cohort has decreased significantly over time.

Kenyavaginose bactériennepublished 2012AIDS (London, England)europe_pmcdocument of 3 observationsDOI 10.1097/qad.0b013e32834ed7f0

76 %Of 16,903 children surveyed, 76% were uninfected with Plasmodium falciparum and not febrile.

Kenyapaludismeobserved 2007–2009published 2010Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/1475-2875-9-99

3.15 days_of_minimum_wageMedicine affordability for chemotherapy cycles in Kenya ranged from 3.15 to 162.42 days of minimum wage per cycle.

Kenyacancer (non précisé)PubMeddocument of 11 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.